| Pharmacokinetic analysis and simplified uptake measures for tumour lesion [18F] F-AraG PET imaging in patients with non-small cell lung cancer JE Wijngaarden, M Slebe, JEE Pouw, DE Oprea-Lager, RC Schuit, ... | | 2024 |
| Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor AA Högnäsbacka, AJ Poot, C Plisson, J Bergare, DR Bonsall, ... EJNMMI research 14 (1), 19, 2024 | 1 | 2024 |
| Development of 18F-Labeled PET Tracer Candidates for Imaging of the Abelson Non-receptor Tyrosine Kinase in Parkinson’s Disease EJL Stéen, AY Park, W Beaino, CG Gadhe, E Kooijman, RC Schuit, ... Journal of medicinal chemistry 66 (18), 12990-13006, 2023 | 1 | 2023 |
| Neuroinflammation in post-COVID individuals with and without persistent complaints 2 years after infection: a [18F] DPA-714 PET study D Visser, SSV Golla, SCJ Verfaillie, A Verveen, DW Koch, RM Rikken, ... European Journal of Nuclear Medicine and Molecular Imaging 50 (SUPPL 1 …, 2023 | | 2023 |
| Synthesis and Preclinical Evaluation of [Methylpiperazine-11C]brigatinib as a PET Tracer Targeting Both Mutated Epidermal Growth Factor Receptor and … AA Högnäsbacka, AJ Poot, E Kooijman, RC Schuit, M Schreurs, ... Journal of medicinal chemistry 66 (17), 12130-12140, 2023 | 2 | 2023 |
| Genome-wide CRISPR screens define determinants of epithelial-mesenchymal transition mediated immune evasion by pancreatic cancer cells L Rotteveel, AJ Poot, EJM Kooijman, RC Schuit, I Schalij, XQ Sun, ... EJNMMI Research 9 (28), 2023 | | 2023 |
| Validation of simplified uptake measures against dynamic Patlak Ki for quantification of lesional 89Zr-Immuno-PET antibody uptake JE Wijngaarden, MC Huisman, YWS Jauw, GAMS van Dongen, ... European journal of nuclear medicine and molecular imaging 50 (7), 1897-1905, 2023 | 11* | 2023 |
| [18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant R Iqbal, M Yaqub, HO Bektas, DE Oprea-Lager, EGE de Vries, ... Clinical Cancer Research 29 (11), 2075-2084, 2023 | 13 | 2023 |
| Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor … A Högnäsbacka, AJ Poot, E Kooijman, RC Schuit, M Schreurs, M Verlaan, ... Nuclear medicine and biology 120, 108349, 2023 | 2 | 2023 |
| Imaging the TGFβ type I receptor in pulmonary arterial hypertension L Rotteveel, AJ Poot, EJM Kooijman, RC Schuit, I Schalij, X Sun, ... EJNMMI research 13 (1), 23, 2023 | | 2023 |
| Assessment of neuroinflammation using [F-18] DPA714 PET in post-COVID-19 patients with and without persisting complaints D Visser, SSV Golla, SCJ Verfaillie, EM Coomans, RM Rikken, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
| Synthesis and preclinical evaluation of [11C] LR111 and [18F] EW-7197 as PET tracers of the activin-receptor like kinase-5 L Rotteveel, K Kurakula, EJM Kooijman, RC Schuit, M Verlaan, ... Nuclear medicine and biology 112, 9-19, 2022 | 2 | 2022 |
| Long COVID is associated with extensive in-vivo neuroinflammation on [18F]DPA-714 PET D Visser, SSV Golla, SCJ Verfaillie, EM Coomans, RM Rikken, ... medRxiv, 2022.06. 02.22275916, 2022 | 23 | 2022 |
| Synthesis and evaluation of 18F-labeled tracer candidates targeting the Abelson non-receptor tyrosine kinase in Parkinson’s disease EJ Stéen, W Beaino, S Jo, H Nam, H Kim, E Kooijman, J Hoozemans, ... Nuclear Medicine and Biology 108, S27, 2022 | | 2022 |
| Biodistribution of 18F-FES in patients with metastatic ER+ breast cancer undergoing treatment with rintodestrant (G1T48), a novel selective ER degrader R Iqbal, M Yaqub, DE Oprea-Lager, Y Liu, AM Luik, AP Beelen, RC Schuit, ... Journal of Nuclear Medicine 63 (5), 694-699, 2022 | 16 | 2022 |
| Relationship between Biodistribution and Tracer Kinetics of 11C-Erlotinib, 18F-Afatinib and 11C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic … EA van de Stadt, M Yaqub, RC Schuit, IH Bartelink, AF Leeuwerik, ... Diagnostics 12 (4), 883, 2022 | 8 | 2022 |
| Correction to Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the Brain B van der Wildt, B Janssen, A Pekosak, EJL Stéen, RC Schuit, ... ACS Chemical Neuroscience 13 (6), 847-847, 2022 | 1 | 2022 |
| Validation and test–retest repeatability performance of parametric methods for [11C]UCB-J PET H Tuncel, R Boellaard, EM Coomans, M Hollander-Meeuwsen, ... EJNMMI research 12 (1), 3, 2022 | 4 | 2022 |
| Long COVID is associated with extensive in-vivo neuroinflammation on DPA-714 PET D Visser, SSV Golla, SCJ Verfaillie, EM Coomans, RM Rikken, ... | | 2022 |
| Synthesis and preclinical evaluation of [C-11] EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor A Hognasbacka, A Poot, C Plisson, J Bergare, S McCluskey, D Bonsall, ... Nuclear medicine and biology 108, S38-S39, 2022 | | 2022 |
